In vivo maturation of human embryonic stem cell-derived teratoma over time

Suemori, 2006, Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage, Biochem Biophys Res Commun, 345, 926, 10.1016/j.bbrc.2006.04.135 Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 Geron, 2010 Schwartz, 2012, Embryonic stem cell trials for macular degeneration: a preliminary report, Lancet, 379, 713, 10.1016/S0140-6736(12)60028-2 Schwartz, 2014, Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies, Lancet 2010 Sallam, 2010, Embryonic stem cell biology: insights from molecular imaging, Methods Mol Biol, 660, 185, 10.1007/978-1-60761-705-1_12 Okamura, 2015, Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum, Genom Data, 6, 4, 10.1016/j.gdata.2015.07.008 Fukawatase, 2014, Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability, Sci Rep, 4, 5421, 10.1038/srep05421 Roach, 2010, Analysis of genetic inheritance in a family quartet by whole-genome sequencing, Science, 328, 636, 10.1126/science.1186802 Kuick, 1992, Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in “spontaneous” germinal mutagenesis, Proc Natl Acad Sci U. S. A, 89, 7036, 10.1073/pnas.89.15.7036 Jackson, 1998, The mutation rate and cancer, Genetics, 148, 1483, 10.1093/genetics/148.4.1483 Tavassoli, 2003, Tumours of the ovary and peritoneum, 168 Walker, 2012, Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors, Cancer Res, 72, 636, 10.1158/0008-5472.CAN-11-2266 Higuchi, 2015, Generation of pluripotent stem cells without the use of genetic material, Lab Invest, 95, 26, 10.1038/labinvest.2014.132 De Assuncao, 2015, Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes, Lab Invest, 95, 684, 10.1038/labinvest.2015.51 Santostefano, 2015, A practical guide to induced pluripotent stem cell research using patient samples, Lab Invest, 95, 4, 10.1038/labinvest.2014.104 Norris, 1976, Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases, Cancer, 37, 2359, 10.1002/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q Trask, 1991, Fluorescence in situ hybridization: applications in cytogenetics and gene mapping, Trends Genet, 7, 149, 10.1016/0168-9525(91)90378-4 Nachman, 2000, Estimate of the mutation rate per nucleotide in humans, Genetics, 156, 297, 10.1093/genetics/156.1.297 Ji, 2012, Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells, Stem Cells, 30, 435, 10.1002/stem.1011 Hayakawa, 2015, A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells, Regen Ther, 2, 70, 10.1016/j.reth.2015.05.001 Akutsu, 2015, Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells, Regen Ther, 1, 18, 10.1016/j.reth.2014.12.004 Lipson, 2006, Efficient calculation of interval scores for DNA copy number data analysis, J Comput Biol, 13, 215, 10.1089/cmb.2006.13.215